Full Description
This issue of Surgical Clinics of North America focuses on Management of Pancreatic Cancer, and is edited by Dr. Avram Cooperman. Articles will include: Is preclinical diagnosis / or prevention of cancer of the pancreas be possible?; Preoperative evaluation of a pancreas mass: diagnostic options; Clinical evaluation of a pancreatic mass: what is essential and practical from a therapeutic standpoint?; Screening of patients at risk for familial pancreatic cancer- what is bene?cial?; Incidental IPMN, cystic /premalignant lesions of the pancreas: the case for selective, conservative management; Preoperative stenting for benign and malignant periampullary cancer: the case for selective application; Preoperative stenting for benign and malignant periampullary diseases: unnecessary if not harmful?; Timing of pancreatic resection and patient outcomes: is there a difference?; Outcome analysis for pancreatic surgery: actual vs actuarial methods?; The role of radiation in pancreatic cancer: the European and American view; Adjuvant or neoadjuvant therapy in the treatment in pancreatic malignancies: Where are we?; Nonoperative Ablation of Pancreatic Neoplasms; Incidental IPMN, cystic/ premalignant lesions of the pancreas: The case for aggressive management; Ex Vivo surgery for low grade tumors involving celiac and superior mesenteric arteries; and more!
Contents
Surgical Clinics of North America
The Pancreas Revisited
Foreword
Preface: A Symposium on Pancreatic Cancer: Time for a Paradigm Shift. An Overview and Personal Reflections
Prevention and Early Detection of Pancreatic Cancer
Preoperative Evaluation of a Pancreas Mass: Diagnostic Options
Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?
Preoperative Stenting for Benign and Malignant Periampullary Diseases: Unnecessary if Not Harmful
A Tale of 2 Techniques: Preoperative Biliary Drainage and Routine Surgical Drainage with Pancreaticoduodenectomy
Timing of Pancreatic Resection and Patient Outcomes: Is There a Difference?
Cancer of the Pancreas-Actual 5, 10, and 20D Year Survival: The Lucky and Fortunate Few
Rare, Uncommon, and Unusual Complications After Pancreaticoduodenal Resection
Adjuvant or Neoadjuvant Therapy in the Treatment in Pancreatic Malignancies: Where Are We?
The Evolving Role of Radiation in Pancreatic Cancer
Nonoperative Ablation of Pancreatic Neoplasms
Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive
Nonfunctioning Incidental Pancreatic Neuroendocrine Tumors: Who, When, and How to Treat?
Rare Tumors and Lesions of the Pancreas
Ex Vivo Resection and Autotransplantation for Pancreatic Neoplasms
